FDA Recalls Potassium Chloride Capsules Due To Dissolution Issue

Signage is seen outside of FDA headquarters in White Oak, Maryland

The Food and Drug Administration (FDA) has issued a recall for two brands of potassium chloride capsules due to concerns that they may not dissolve properly, potentially leading to serious health risks, including heart attacks.

Glenmark Pharmaceuticals Inc. is recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K, intended for patients with low potassium levels (hypokalemia). The recall is due to 'failed dissolution' in the pills, which could elevate potassium levels and increase the risk of a heart attack.